使用沃顿商学院的果冻间充质干细胞治疗 COVID-19 患者
Brief Summary:本研究的目的是调查沃顿果冻间充质干细胞的潜在用途 (WJ-MSCs) 用于治疗被诊断患有冠状病毒 SARS-CoV-2 感染的患者, 并表现出 COVID-19 症状.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Use of干细胞 for COVID-19 Treatment | Biological: WJ-MSCs | Phase 1 |
详细说明:
COVID-19 is a condition caused by infection with Coronoa Virus (SARS-CoV-2). This virus has a high transmission rate and is spreading at very high rates. causing a worldwide pandemic. Patients diagnosed with COVID-19 and confirmed positive with the virus, will be given three IV doses of WJ-MSCs consisting of 1X10e6/kg. The three doses will be 3 days apart form each other.
Patients will be followed up for a period of three weeks to assess the severity of the condition and measure the viral titers.
